![Marek Poszepczynski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Marek Poszepczynski
Eerdere bekende functies van Marek Poszepczynski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 01-04-2012 | 01-03-2017 |
SVENSKA HANDELSBANKEN AB | Corporate Officer/Principal | 01-01-2010 | 01-01-2012 |
KAROLINSKA DEVELOPMENT AB | Corporate Officer/Principal | 01-01-2008 | 01-01-2010 |
Biovitrum AB
![]() Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01-01-2002 | 01-01-2008 |
SV Health Investors LLP
![]() SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | - | - |
Svenska Handelsbanken AB (Broker)
![]() Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Analyst-Equity | 26-05-2011 | - |
Axelar AB
![]() Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Corporate Officer/Principal | 29-10-2009 | - |
Opleiding van Marek Poszepczynski
Royal Institute of Technology | Graduate Degree |
Statistieken
Internationaal
Zweden | 8 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 5 |
Analyst-Equity | 1 |
Graduate Degree | 1 |
Sectoraal
Finance | 5 |
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CALLIDITAS THERAPEUTICS AB | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
SVENSKA HANDELSBANKEN AB | Finance |
Bedrijven in privébezit | 4 |
---|---|
Axelar AB
![]() Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Svenska Handelsbanken AB (Broker)
![]() Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Finance |
Biovitrum AB
![]() Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
SV Health Investors LLP
![]() SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
- Beurs
- Insiders
- Marek Poszepczynski
- Ervaring